Close Menu

NEW YORK – Advanced Biological Laboratories announced Thursday its UltraGene Combo2Screen SARS-CoV-2 test received CE-IVD marking. 

The real-time RT-PCR test targets the N gene and E gene regions of the SARS-CoV-2 genome and requires a nasopharyngeal swab specimen. The assay is compatible with "most automatic or manual RNA extraction methods," along with qPCR instruments with at least three channels, the Luxembourg-based company said. Its turnaround time is less than two hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.